Enteric infection in relapse of inflammatory bowel disease: Importance of microbiological examination of stool

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 8, 2004, Pages 775-778

  Mylonaki, Maria ^a   Langmead, Louise ^a   Pantes, Athanasios ^a   Johnson, Frith ^a   Rampton, David S ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Clostridium difficile; Crohn's disease; Enteric infection; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM TOXIN; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; MYCOPHENOLIC ACID; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; BACTERIAL SUPERINFECTION; BLASTOCYSTIS HOMINIS; CAMPYLOBACTER; CLOSTRIDIUM DIFFICILE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DISEASE ASSOCIATION; ENTAMOEBA HISTOLYTICA; ENTERITIS; FECES ANALYSIS; FECES CULTURE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PLESIOMONAS SHIGELLOIDES; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; REVIEW; SALMONELLA; STRONGYLOIDES STERCORALIS; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; COLITIS; COLITIS, ULCERATIVE; CROHN DISEASE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMANS; INTESTINAL DISEASES; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 4043089351     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000131040.38607.09     Document Type: Review

References (25)

1. Hermens DJ, Miner PB. Exacerbation of ulcerative colitis. Gastroenterology 1991; 101:254-262.
2. Kochhar R, Ayyagari A, Goenka MK, Dhali GK, Aggarwal R, Mehta SK. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol 1993; 16:26-30.
3. Gurian L, Klein K, Ward TT. Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease. West J Med 1983; 138:359-360.
4. Bolton RP, Sheriff RJ, Read AE. Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease? Lancet 1980; i:383-384.
5. Trnka Y, LaMont JT. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology 1981; 80:693-696.
6. Kressner MS, Williams SE, Biempica L, Das KM. Salmonellosis complicating ulcerative colitis. Treatment with trimethoprim-sulfamethoxazole. J Am Med Assoc 1982; 248:584-585.
7. Weber P, Koch M, Heizmann WR, Scheurlen M, Jenss H, Hartmann F. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol 1992; 14:302-308.
8. Szilagyi A, Gerson M, Mendelson J, Yusuf NA. Salmonella infections complicating inflammatory bowel disease. J Clin Gastroenterol 1985; 7:251-255.
9. Rampton DS, Salmon PR, Clark CG. Nonspecific ulcerative colitis as a sequel to amebic dysentery. J Clin Gastroenterol 1983; 5:217-219.
10. Rolny P, Jarnerot G, Mollby R. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Scand J Gastroenterol 1983; 18:61-64.
11. Lamont JT, Trnka YM. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet 1980; i:381-383.
12. Bowman RA, Riley TV. Routine culturing for Clostridium difficile? Pathology 1984; 16:240-242.
13. Dallai RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235: 363-372.
14. Meyers S, Mayer L, Bottone E, Desmond E, Janowitz HD. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 1981; 80:697-700.
15. Keighley MR, Youngs D, Johnson M, Allan RN, Burdon DW. Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease. Gut 1982; 23:410-414.
16. Greenfield C, Aguilar Ramirez JR, Pounder RE, Williams T, Danvers M, Marper SR, Noone P. Clostridium difficile toxin and inflammatory bowel disease. Gut 1983; 24:713-717.
17. Burke DA, Axon ATR. Clostridium difficile, sulphasalazine and ulcerative colitis. Postgrad Med J 1987; 63:955-957.
18. Bartlett JG, Laughon BE, Bayless TM. Role of microbial agents in relapses of inflammatory bowel disease. In: Bayless TM (editor): Current Management of Inflammatory Bowel Disease. St Louis: Mosby; 1989, pp. 86-91.
19. Markowitz JE, Brown KA, Mamula P, Drott HR, Piccoli DA, Baldassano RN. Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease. Am J Gastroenterol 2001; 86:2688-2690.
20. Hyams JS, McLaughlin JC. Lack of relationship between Clostridium difficile toxin and inflammatory bowel disease in children. J Clin Gastroenterol 1985; 7:387-390.
21. Brown WJ, Hudson MJ, Patrick S, Matthews SC, Hill MJ, Gent AE, et al. Search for enteric microbial pathogens in patients with ulcerative colitis. Digestion 1992; 53:121-128.
22. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhoea. A review. Arch Intern Med 2001; 161:525-533.
23. Pokorney BH, Nichols TW. Pseudomembranous colitis. A complication of sulfasalazine therapy in a patient with Crohn's colitis. Am J Gastroenterol 1981; 76:374-376.
24. Lysy J, Zimmerman J, Sherman Y, Feigin R, Ligumsky M. Crohn's colitis complicated by superimposed invasive amebic colitis. Am J Gastroenterol 1991; 86:1063-1065.
25. Anon. Misdiagnosis of amoebiasis. Br Med J 1978; ii:379-380.